The previous posts narrowed the problem. Some people appear reactive to heat. Protocol metadata is thin. Cold pairing...

The previous posts narrowed the problem. Some people appear reactive to heat. Protocol metadata is thin. Cold pairing confounds outcomes. Women's hormonal context is under-measured. Steam Collective now needs a first study shape that is small enough to run and clear enough to vote on later.

Proposal: a low-and-slow heat titration study for self-identified heat-reactive or histamine-sensitive users.

This is not a claim that gentle heat cures histamine issues. It is a proposal to test whether a lower-dose, carefully progressed protocol is tolerable, and whether tolerance or symptoms change over weeks under consistent logging.

Why this study first

A first community study should do three things at once:

• serve a real user population that current sauna discourse often ignores
• force the metadata standard into practice
• create a template for later, larger trials

High-intensity contrast protocols are a poor starting point for reactive users. They stack stressors before baseline tolerance is known. A low-and-slow design asks a more basic question: can heat be introduced in a way that remains usable?

Draft protocol family

Exact parameters should be refined in public before launch. A starting shape:

• traditional or controlled dry heat when available
• lower starting temperature than standard Finnish performance sessions
• shorter initial rounds
• passive cooling only in the first phase
• no cold plunge during the titration window
• session frequency capped and progressed only after symptom review
• stop rules for flushing, airway symptoms, severe headache, sleep collapse, or prolonged next-day flare

The point of titration is not heroics. It is finding the highest tolerable dose that still looks adaptive rather than provocative.

Endpoints

Minimum endpoints for a decentralised cohort:

• session completion and adherence
• acute symptom score during and immediately after heat
• 24-hour symptom score
• sleep quality
• resting HR / HRV when available
• temperature and duration actually completed
• reason for any dose reduction or stop

Optional additions later: validated questionnaires, clinician partnership, or lab markers. They are not required to justify a community pilot.

Inclusion and caution

Participants would be adults who self-report heat sensitivity, histamine intolerance, or mast-cell-type reactivity and who consent to structured logging. This remains observational community research, not personalised medical care. People with unstable disease, recent severe reactions, or clinician guidance against heat exposure should not be pushed into the protocol.

Steam Collective's job is to make the uncertainty visible and the data useful, not to replace clinical judgment.

Why this is governance-ready

A good first study proposal is specific enough that the community can argue about it productively:

• Is low-and-slow the right first arm?
• Should women's hormonal stratification be required from day one?
• Should cold pairing stay excluded until phase two?
• What stop rules are non-negotiable?

Those are design choices. They belong in the open. Once they are settled, P16 can turn the broader research agenda into a funding decision.

The first study should prove that Steam Collective can define a protocol, protect participants, log the dose, and learn in public.